Please ensure Javascript is enabled for purposes of website accessibility

Applications | Design & Manufacturing | Cell & Gene Therapy

Streamline cell & gene therapy manufacturing from concept to cure

Whether you’re treating degenerative conditions, autoimmune disorders, or cancer by targeting disease at the cellular level, or developing living therapeutics to restore or enhance tissue function to advance more complex disease research, Ascential is ready to support your processes. Our team’s bandwidth and expertise help you scale your cell and gene therapy (CGT) manufacturing throughput with expertise such as:

  • Automated Manufacturing Platforms (CAR-T, TCR-T, NK Cell Workflows)
  • Non-Viral Transfection and Cell Engineering Instruments
  • Closed-System Cell Processing and Handling Instrumentation
  • Viral Vector Production Support Platforms
  • Cell Washing, Concentration, and Formulation Systems
  • Cryogenic Handling Hardware Systems
  • Single-Use Fluidic Assemblies and Sterile Consumables
  • Cell Therapy Workflow Automation and GMP-Ready Equipment

Get Your 15-Minute Consultation

Solutions

Design advanced cell & gene therapy workflows for regulatory readiness

Ensure each system is built for precision control of sensitive biological materials — from early research through GMP implementation. Our experts work cross-functionally to design instruments that meet the rigorous demands of clinical-scale CGT production. Whether you’re optimizing one process or building an end-to-end workflow, we design solutions that focus on performance, reproducibility, and regulatory readiness, so that you can scale your therapy with confidence.

Cell Therapy Platform Development

Enhance GMP-readiness with full instrument design from concept through production. We can engineer closed-system fluidic architecture; low-shear pumping and flow control; aseptic connector integration, automation, and controls; environmental enclosure design; and instrument control software.

Fluidic Assembly & Consumable Development

Build sterile tubing manifolds and disposable flow paths for volume manufacturing processes and integrate fluidic kits engineered for biocompatibility, leak integrity, sterilization compatibility, and high cell recovery.

Aseptic System Architecture & Contamination-Controlled Design

Reduce cross-contamination for platforms operating in GMP environments with sealed fluidic paths, aerosol containment, and cleanroom- compatible mechanical design.

Prototype & Alpha Platform Builds

Validate cell handling performance and de-risk architecture decisions with early process development support. Our experts deliver rapid functional prototypes and alpha-stage systems.

Sustaining Engineering & Cost Optimization

Yield improvement, resolve component obsolescence, and strengthen program reliability for fielded cell therapy platforms.

Capabilities

Manufacturing for biological performance & seamless scale-up

We manufacture platforms that are engineered to preserve your existing cell viability and recovery rates and meet GMP contamination control requirements by design. By reducing operator variability and compressing processing time, our scalable architectures support your therapy’s seamless progression from early clinical research to commercial volume production without fundamental redesign.

Closed-System & Aseptic Fluidic Architecture

Maintain batch integrity by designing cross-contamination mitigation into the system architecture. Ascential routinely works on sealed fluidic paths with sterile connector integration, leak-proof flow path engineering, aerosol containment, and surface material selection validated for sterilization compatibility.

Consumable Design for Spatial Workflows

Preserve tissue integrity and minimize edge effects with designs engineered for uniform reagent distribution, clear optical windows, and consistent instrument interfaces. We ensure spatial data is artifact-free and reproducible across the full sample.

Low-Shear Cell Handling & Flow Control

Minimize cell loss and activation during processing steps with pump selection and flow path geometry designed to minimize shear stress on fragile cell populations. Our team’s intentional automation approach protects your biology from controlled flow rates, to bubble detection and elimination, to precision volume metering, to high-recovery fluid transfer paths.

GMP-Ready Design & Manufacturing

Ensure equipment holds up to regulatory scrutiny without a retrofit cycle. Our team handles design controls per ISO 13485; risk management per ISO 14971; requirements traceability; verification and validation execution; DFM for cleanroom production; electrical safety and EMC compliance; and design transfer to manufacturing environments with the contamination control and documentation requirements of cell therapy equipment production.

Case Study

Engineering scalable cell therapy platforms for clinical success

An integrated development and manufacturing organization (IDMO) needed to transition from a lab prototype to low-volume manufacturing and sought to implement rapid bill of materials (BOM) changes, as well as infrastructure and packaging design for the assembly of large, heavy subsystems. Ascential developed new assembly and testing procedures, resolved production issues, and redesigned key subsystems with minimal disruption. In just 5 months, our team loaded a 10,000-item BOM with 20 sub-assemblies​, sourced components, and finalized the first product batch. Our process optimization enabled ocean delivery of the organization’s 12,000-lb instruments worldwide.

Now, the IDMO has a fully integrated, scalable, cGMP cell therapy manufacturing platform that was FDA certified as an Advanced Manufacturing Technology (AMT) and proved critical to clinical trial collaborations with pharmaceuticals.​

Why Choose Ascential?

When you engage our team, you tap into 70+ years of experience delivering mission-critical solutions that bridge precision engineering, automation, and medical manufacturing knowledge from 7 highly specialized firms.
Artificial Intelligence Icon

CGT Manufacturing Domain Expertise

We evaluate pumps against shear-induced cell damage thresholds and characterize any fluidic dead volumes against your cell recovery targets.

Artificial Intelligence Icon

Integrated Engineering

Resolve material placement, design, and automation trade-offs in real time with our cross-collaborative team. We help you strengthen coordination between your fluidic architecture, automation sequencing, contamination control, and consumable interfaces.

Artificial Intelligence Icon

GMP-Aware Manufacturing

Ensure designs fit manufacturing constraints from early development through execution. Ascential produces CGT manufacturing equipment at our ISO 13485-compliant sites, with cleanroom production capability, to centralize and streamline production efforts.

Artificial Intelligence Icon

Complex Consumable & Production Automation

Improve and scale quality assurance with thoughtful automation integration, which can include cleanroom assembly, leak testing, sterile packaging, bonding, and in-line inspection. We design, build, and support automated production lines for high-precision life sciences consumables.

Frequently Asked Questions

Get answers to common questions about our cell and gene therapy capabilities.

No. We engineer the instrument platforms, automation systems, and consumables. Your team owns the biology and therapeutic process. We engineer the hardware to execute that process reliably, aseptically, and at scale.
Ascential has built automated cell therapy manufacturing platforms and cell engineering instruments that are in commercial use. Our teams understand the specific engineering requirements: closed-system aseptic architecture, low-shear cell handling, sterile consumable interfaces, and GMP-ready equipment design.

Yes. Ascential engineers disposable flow paths, tubing manifolds, sterile connector interfaces, and integrated fluidic kits designed for biocompatibility, leak integrity, sterilization compatibility, and volume manufacturing.

Spatial platforms require tighter subsystem coordination than most instruments: the timing between fluidic delivery, thermal setpoints, stage moves, and image acquisition all interact. Ascential experts have direct experience managing these interactions at the systems engineering level, with all subsystem disciplines in-house.

A cell therapy instrument program from concept through design verification typically runs 18-30 months. Closed-system platforms with complex automation and GMP requirements tend toward the longer end. Rapid alpha platforms to de-risk architecture can be delivered significantly faster.

Either. Ascential routinely integrates client-preferred suppliers for biocompatible tubing, sterile connectors, pumps, and valves. Where you don’t have a preference, we use our qualified supply base. For components critical to cell contact and sterility, we recommend qualifying alternatives early.

Related Resources